Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Zh Nevrol Psikhiatr Im S S Korsakova ; 124(5. Vyp. 2): 39-52, 2024.
Article de Russe | MEDLINE | ID: mdl-38934665

RÉSUMÉ

Insomnia is a serious and widespread public health problem, but is often undetected and patients do not receive needed treatment. Insomnia is often comorbid with other diseases and conditions, such as arterial hypertension, type 2 diabetes mellitus, pain syndromes, anxiety and depressive disorders, etc. A separate problem is drug-induced insomnia, when patients develop symptoms due to other diseases treatments. Insomnia has a negative effect on the prognosis of comorbid diseases, including an increased risk of death, more severe disease, and decreased quality of life. The presence of sleep disorders makes it difficult to effectively treat the underlying disease, so clinical guidelines draft for the evaluation and treatment of insomnia in multimorbid patients is proposed. Diagnostic methods are reviewed and recommendations are given for the treatment of acute and chronic insomnia and features of the treatment of insomnia in multimorbid patients. A clinical algorithm has been proposed to determine treatment tactics in multimorbid patients.


Sujet(s)
Guides de bonnes pratiques cliniques comme sujet , Troubles de l'endormissement et du maintien du sommeil , Humains , Multimorbidité , Qualité de vie , Troubles de l'endormissement et du maintien du sommeil/thérapie , Troubles de l'endormissement et du maintien du sommeil/épidémiologie , Troubles de l'endormissement et du maintien du sommeil/diagnostic
2.
Zh Nevrol Psikhiatr Im S S Korsakova ; 123(5. Vyp. 2): 49-57, 2023.
Article de Russe | MEDLINE | ID: mdl-37275998

RÉSUMÉ

Sleep disorders are becoming increasingly important due to the high comorbidity with other diseases and a significant impact on the patient's quality of life. Insomnia is the most common sleep disorder both in the general population and in patients with multimorbid pathology. Its prevalence in the general population is 6-15%, while in patients with somatic diseases it increases up to 20-40% and can reach 90% in patients with comorbid mental disorders. Another problem is the development of drug-induced insomnia. Insomnia has negative impact on the prognosis of comorbid diseases, including an increased risk of death, more severe disease, and a worse quality of life. The presence of sleep disorders makes it difficult to effectively treat the underlying disease, so it is extremely important to identify and correct these disorders in the early stages, therefore recommendations for the diagnosis of insomnia in polymorbid patients are proposed. Modern methods of treating acute and chronic insomnia and features of insomnia treatment in polymorbid patients are also discussed.


Sujet(s)
Troubles de l'endormissement et du maintien du sommeil , Troubles de la veille et du sommeil , Humains , Troubles de l'endormissement et du maintien du sommeil/épidémiologie , Troubles de l'endormissement et du maintien du sommeil/thérapie , Consensus , Qualité de vie , Comorbidité , Troubles de la veille et du sommeil/épidémiologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE